Royal jelly (RJ) is known to have a variety of biological activities toward various types of cells and tissues of animal models, but nothing is known about its effect on brain functions. Hence, we examined the effect of oral administration of RJ on the mRNA expression of various neurotrophic factors, their receptors, and neural cell markers in the mouse brain. Our results revealed that RJ selectively facilitates the mRNA expression of glial cell line-derived neurotrophic factor (GDNF), a potent neurotrophic factor acting in the brain, and neurofilament H, a specific marker predominantly found in neuronal axons, in the adult mouse hippocampus. These observations suggest that RJ shows neurotrophic effects on the mature brain via stimulation of GDNF production, and that enhanced expression of neurofilament H mRNA is involved in events subsequently caused by GDNF. RJ may play neurotrophic and/or neuroprotective roles in the adult brain through GDNF.
The population of the Western world is progressively aging. This increase in the elderly population will mean an increase in the prevalence of age-related cognitive decline and neuropsychiatric disorders such as Alzheimer's disease and depression, which are nowadays a predominant health care problem in the elderly. Recent investigations suggest that neurotrophic factors are involved in the etiology and/or development of these diseases and that enhanced synthesis of particular neurotrophic factors may be expected to be a promising avenue for protection against them. [1] [2] [3] Royal jelly (RJ), which is fed to the queen honeybee, is thought to play important nutritional roles in the queen, and it has been reported to have a variety of biological activities toward various types of cells and tissues of animal models. For instance, RJ ameliorates the physical fatigue after exercise, 4) exhibits immunomodulatory properties, [5] [6] [7] and inhibits the development of atopic dermatitis-like skin lesions. 8) Peptides derived from protease-treated RJ have an anti-hypertensive effect on spontaneously hypertensive rats. 9) Further, it should be noted that these effects of RJ were mostly obtainable by oral administration. 4, 8, 9) But so far there are no reports showing neurotrophic and/or neuroprotective effects of RJ. Hence, in the present study, we examined the influence of oral administration of RJ on the mRNA expression of various neurotrophic factors, their receptors, and neural cell markers.
Our present results revealed that RJ can selectively facilitate the mRNA expression of glial cell line-derived neurotrophic factor (GDNF) and neurofilament H, a protein specifically expressed in neuronal axons, in the hippocampus of the adult mouse brain, but not that of other neurotrophic factors, their receptors, or neural cell markers. These observations suggest that orally-administered RJ would have neurotrophic action and/or neuroprotective effects on the mature brain via GDNF production.
Materials and Methods
Animals and administration of RJ. Male ddy mice (5 y To whom correspondence should be addressed. Fax: +81-58-237-8589; E-mail: furukawa@gifu-pu.ac.jp Abbreviations: BDNF, brain-derived neurotrophic factor; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GDNF, glial cell line-derived neurotrophic factor; GFAP, glial fibrillary acidic protein; MAP2, microtubule-associated protein 2; MBP, myelin basic protein; MRJP, major royal jelly protein; NFH, neurofilament H; NGF, nerve growth factor; NT, neurotrophin; RJ, royal jelly; RT-PCR, reverse transcription-polymerase chain reaction weeks, Nippon SLC, Shizuoka, Japan) were cared for according to the Guidelines of Experimental Animal Care issued by the Office of the Prime Minister of Japan. Mice were fed normal food for 2 weeks to become accustomed to their environment, and were then divided into 3 groups, each composed of 4 individuals. The first group was fed normal food (certified diet food, ME, Oriental Yeast) without RJ for 10 d; the second group, normal food containing 1% (w/w) lyophilized RJ (RJ food) for 3 d; and the third group, the RJ food for 10 d. The RJ food was prepared by Oriental Yeast Co., Ltd.
Evaluation of mRNA expression in the brain. The brain was dissected from anesthetized animals of each of the 3 groups. Total RNA was prepared from the brains of each mouse using Isogen (Nippon Gene, Tokyo), which is basically composed of guanidine isothiocyanate. Reverse transcription-polymerase chain reaction (RT-PCR) was performed as described previously 10) using a SMART PCR cDNA Synthesis Kit (Clontech, Palo Alto, CA). In brief, 500 ng of RNA was denatured for 2 min at 70 C and reverse-transcribed with 1 mM CDS primer by SUPERSCRIPT II RNase H-Reverse Transcriptase (Invitrogen, Carlsbad, CA) for 1 hr at 42 C. Amplification of the synthesized cDNA by PCR was carried out in a thermal cycler at 94 C for 3 min, followed by appropriate cycles of 94 C for 30 sec, 55 C for 30 sec, and 72 C for 30 sec. The products were electrophoresed on 2% agarose gels and stained with ethidium bromide solution. The target genes, structure of primers, predicted size of amplified cDNA fragments, number of PCR cycle, and annealing temperature are indicated in Table 1 . Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was used as an internal control. The intensity of the bands was analyzed by use of image analysis software (Mac BAS, Fuji Film, Tokyo).
Results
The amount of food taken by each group (n ¼ 4) was 27:8 AE 0:7 g/day (the first group, normal food for 10 d), 28:6 AE 0:6 g/day (the second group, RJ food for 3 d), and 28:0 AE 0:6 g/day (the third group, RJ food for 10 d). There was no significant difference among the 3 groups, suggesting that RJ did not affect their eating behavior. The body weight of the group fed the normal food (n ¼ 4) was 43:6 AE 0:9 g after 3 d, and 45:2 AE 0:8 g after 10 d , and that of the groups fed the RJ food (n ¼ 4 for each) was 43:0 AE 0:6 g (fed for 3 d) and 46:0 AE 1:7 g (fed for 10 d). Therefore, RJ food did not influence the increase in body weight when fed for 3 or 10 d. Furthermore, gross appearance and apparent locomotion activity were not different between either group given RJ food and the group fed normal food.
Next, we examined the effect of RJ on the mRNA expression of neurotrophic factors and their receptors in the mouse hippocampus. The neurotrophic factors examined included nerve growth factor (NGF), brainderived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), neurotrophin-4/5 (NT-4/5), GDNF, and neurotrophic factor receptors, high-affinity receptors TrkA, TrkB, and TrkC, low-affinity receptor p75, and GDNFbinding component GFR1. 11, 12) Total RNA was prepared from the hippocampus of each mouse and used for RT-PCR analysis of all target cDNAs. Typical expression patterns are shown in Fig. 1A . They indicate that RJ affected only the level of GDNF mRNA. The intensity of the PCR band derived from GDNF cDNA in the hippocampus significantly rose after RJ administration for 3 or 10 d (Fig. 1B) .
Used in the present study, RT-PCR is a very sensitive technique to measure and to compare mRNA levels among samples. But it is not easy to maintain accurate quantification, due to the narrow range of linearity between the concentration of the cDNA template and the amount of PCR products. Hence, we carefully checked the reliability of the RT-PCR used in the current study. To find the range of linearity at the PCR amplification step, we inserted various amounts of GDNF cDNA into the pBluescript KS À vector (standard GDNF cDNA), or of NGF cDNA into the pGW1 vector (standard NGF cDNA), and amplified them under the conditions described in ''Materials and Methods'' and Table 1 . The intensity of fluorescence, implying the amount of PCR products, was plotted against the concentrations of standard GDNF cDNA, or concentrations of standard NGF cDNA used as a template. An almost linear relationship was observed in the intensity of fluorescence of GDNF PCR products from 150 to 1,050, and in the intensity of fluorescence of NGF PCR products from 110 to 1,000. The intensities of the RT-PCR products for GDNF and NGF cDNA transcribed from total RNAs of the hippocampus of mice fed RJ food for 0, 3, or 10 d were plotted, and were found to be within the linear range of the respective dose-response curves ( Fig. 2A,  B) , showing that the concentration of GDNF or NGF cDNA can be measured accurately. Since the amount of PCR products for GDNF cDNA transcribed from the mice fed RJ food for 3 or 10 d was significantly higher than that of those fed no RJ food, the concentration of GDNF cDNA was also significantly higher in the group fed RJ food for 3 or 10 d than in the group fed no RJ food ( Fig. 2A) . But the amount of PCR products of NGF cDNA was unchanged irrespective of RJ feeding, resulting in no difference in the NGF mRNA among test samples, similarly to the result indicated in Fig. 1 .
Furthermore, the addition of standard cDNA of GDNF or NGF (an increase of 40 fM in the PCR reaction) to the sample cDNAs of the group fed no RJ food (fed for 0 d) increased the intensity of fluorescence just as expected theoretically from the respective doseresponse curves (data not shown). This result indicates that the amplification efficiency of the sample cDNA was nearly equal to that of standard cDNA, suggesting that the amount of GDNF cDNA or NGF cDNA in the samples was determined accurately.
Similar experiments indicated that the current RT-PCR method can also accurately and reliably compare the relative amounts of target mRNAs other than GDNF and NGF mRNAs, because the values were within the linear range of the respective dose-response curves (data not shown). Hence, data are expressed as the foldincrease in the ratio of the amounts of target cDNA/the amounts of GAPDH cDNA for easy comparison hereinafter (Figs. 3 and 4) . Mice were fed normal food or food containing 1% (w/w) RJ (RJ food) for 3 or 10 d. The hippocampus was dissected from the anesthetized animals, and total RNA was prepared from this brain region of each mouse. Each total RNA sample was subjected to RT-PCR using primers specific for the respective target genes, and PCR products were applied to 2% agarose gels. The gels were stained with ethidium bromide, and photographs were taken. (A) Photographs of the bands corresponding to cDNAs derived from each mRNA. (B) Statistically significant increase in GDNF mRNA expression. The bands corresponding to neurotrophic factor mRNAor GAPDH mRNA-derived cDNA were densitometrically quantified, and the ratio of the intensity of each neurotrophic factor band to that of the GAPDH band (the ratio of neurotrophic factor/GAPDH) was calculated. The values are expressed as the means AE S.E. (n ¼ 4) of the fold-increase in the ratio, regarding the value of the mice fed normal food (zero d) as 1.0. Significance of differences from the control values was determined by using ANOVA with Tukey's post hoc test. Significance, *p < 0:05 vs. zero d.
The expression level of GDNF mRNA was investigated in various brain regions including the hippocampus. Significant upregulation was found in the cerebral cortex, but the levels in the diencephalon, mesencephalon, cerebellum, and spinal cord were unchanged (Fig. 3) . To obtain further insight into the effects of RJ on brain cells, we evaluated by RT-PCR the level of mRNAs of proteins that are specifically expressed in particular brain cells or structures such as neurofilament H (NFH, a marker for neuronal axons), microtubule-associated protein 2 (MAP2, a marker for neuronal cell bodies and dendrites), glial fibrillary acidic protein (GFAP, a marker for astrocytes), and myelin basic protein (MBP, a marker for oligodendrocytes). RJ facilitated the mRNA expression of NFH, but not that of MAP2, GFAP, or MBP (Fig. 4) , suggesting enhancement of some neuronal and/or axonal functions by RJ. This might be the first report of evidence showing a neurotrophic influence of RJ feeding on brain function.
Discussion
In the present study, we evaluated the mRNA expression of genes related to neurotrophic factors and GDNF mRNA expression in various brain regions of the mice fed RJ food was investigated by RT-PCR. The bands corresponding to GDNF and GAPDH mRNA-derived cDNA were densitometrically quantified, and the ratio of the intensity of the GDNF band to that of the GAPDH band (the ratio of GDNF/GAPDH) was calculated. The values are expressed as the means AE S.E. (n ¼ 4) of the foldincrease in the ratio of GDNF/GAPDH, regarding the value of the mice fed normal food (zero d) as 1.0. Significance of difference from the control value was determined by Student's t-test. Significance, *p < 0:05 vs. corresponding zero d value. their receptors and to cell markers in the mouse brain by RT-PCR before and after oral administration of RJ. It has been thought, however, that the RT-PCR method is problematic in terms of accurate quantification of mRNA, because huge amplification of DNA tends to disrupt the linearity between the amount of cDNA products and the concentration of template cDNA. 13, 14) Although real-time PCR provides high-throughput quantification, it is not easily accessible to every gene due to unexpected amplification of non-target genes. Furthermore, it is not cost-effective for experiments examining only a few sample pairs. Hence, we carefully performed RT-PCR in which the linearity between the concentration of cDNA template and the amount of PCR products was guaranteed (Fig. 2) .
Our present study indicates that orally administered RJ selectively enhanced the gene expression of GDNF, a representative neurotrophic factor that functions in the brain. GDNF was originally purified and cloned as a survival factor for cultured midbrain dopaminergic neurons, 15) and was later shown to promote the survival of spinal motoneurons. 16, 17) Many investigators have found that exogenously added GDNF has prominent protective action against the death of nigrostriatal dopaminergic neurons, 18) ischemic brain damage, 19) and traumatic brain injury. 20) These observations suggest that endogenous GDNF might similarly be expected to act protectively against certain neurological disorders that are on the increase in the elderly. Deprenyl and melatonin, therapeutic agents for Parkinson's disease, are reported to enhance GDNF mRNA expression in drug-injected brain areas, 21) suggesting therapeutic mechanisms of these agents. Earlier we showed that compounds with NGF or BDNF synthesis-stimulating activities protect against peripheral neuropathies that accompany diabetes or neurotoxin administration. 22, 23) These observations indicate that the up-regulation of neurotrophic factor synthesis such as that of GDNF and other neurotrophins is one of the promising ways to protect against or treat neurological disorders. From this point of view, through the up-regulation of GDNF gene expression, RJ might also be protective of dopaminergic neurons, which are severely damaged in Parkinson's disease.
Furthermore, oral administration of RJ can increase the mRNA expression of NFH in the hippocampus. This might be one of the consequences of the action of the GDNF induced by RJ, because GDNF is known to promote neurite outgrowth and to stimulate neuronal differentiation that leads to enhanced expression of NFH. However, although we have no evidence at the present to decide whether enhanced NFH mRNA is dependent on or independent of induced GDNF, it is true that RJ administration elicits NFH mRNA expression. Further investigation is necessary to address the physiological significance of enhanced expression of NFH.
It should be noted that GDNF and NFH mRNAs are elevated by oral administration of RJ in the same way as other biological activities found in RJ, 4, 8, 9) suggesting that the unknown active components in RJ can pass through the blood-brain barrier. Proteins are major components of RJ, 24) and various biological activities of RJ proteins have been identified. Among the major RJ protein species, 25) MRJP1 promotes liver regeneration via cytoprotective action on hepatocytes, 26) and MRJP3 exhibits potent immunoregulatory effects. 27) Royalisin has antibacterial activity against Gram-negative bacteria. 28) Proteins are macromolecules that cannot cross the blood-brain barrier; only digested small peptides or amino acids can cross it. The generation of biologically active small peptides during digestion is plausible, because physiologically important activity has been found in peptides from enzyme-treated RJ proteins. 9) Alternatively, a non-protein component of RJ such as trans-10-hydroxy-2-decenoic acid, which exhibits antibacterial activity, 29) might be involved in the regulatory mechanisms of GDNF and/or NFH gene expression.
Identification of the active component(s) that upregulate gene expression and evaluation of the effects of RJ on brain functions such as learning and memory are important future tasks, whose completion will allow us better to estimate the potential of RJ in health care and/ or clinical use in the treatment of various neurological disorders.
